Micro-invasive pancreaticoduodenectomy will be a promising treatment option for distal cholangiocarcinoma.
作者信息
Wang Han-Xuan, Wang Zu-Yu, Lang Ren, He Qiang, Lyu Shao-Cheng
机构信息
Department of Hepatobiliary and Pancreaticosplenic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
出版信息
Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):841-844. doi: 10.21037/hbsn-24-331. Epub 2024 Sep 5.
Abstract
摘要
相似文献
1
Micro-invasive pancreaticoduodenectomy will be a promising treatment option for distal cholangiocarcinoma.微创胰十二指肠切除术将是治疗远端胆管癌的一种有前景的选择。
Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):841-844. doi: 10.21037/hbsn-24-331. Epub 2024 Sep 5.
2
Long-term Outcomes After Laparoscopic, Robotic, and Open Pancreatoduodenectomy for Distal Cholangiocarcinoma: An International Propensity Score-matched Cohort Study.腹腔镜、机器人和开放胰十二指肠切除术治疗远端胆管癌的长期结果：一项国际倾向评分匹配队列研究。
Ann Surg. 2023 Sep 1;278(3):e570-e579. doi: 10.1097/SLA.0000000000005743. Epub 2022 Nov 1.
3
Comparison of postoperative complications and long-term oncological outcomes in minimally invasive versus open pancreatoduodenectomy for distal cholangiocarcinoma: A propensity score-matched analysis.微创与开腹胰十二指肠切除术治疗远端胆管癌的术后并发症和长期肿瘤学结局比较：倾向评分匹配分析。
J Hepatobiliary Pancreat Sci. 2022 Mar;29(3):329-337. doi: 10.1002/jhbp.1067. Epub 2021 Nov 10.
4
Minimally invasive versus open pancreaticoduodenectomy for distal bile duct cancer: an inverse probability of treatment weighting analysis of outcomes.微创与开放胰十二指肠切除术治疗远端胆管癌：治疗结局的逆概率加权分析
Surg Endosc. 2023 Feb;37(2):881-890. doi: 10.1007/s00464-022-09533-y. Epub 2022 Aug 26.
5
Pancreaticoduodenectomy for distal cholangiocarcinoma at a South African centre.南非中心行胰十二指肠切除术治疗远端胆管癌。
S Afr J Surg. 2024 May;62(2):39-43.
6
The clinical implication of minimally invasive versus open pancreatoduodenectomy for non-pancreatic periampullary cancer: a systematic review and individual patient data meta-analysis.微创与开腹胰十二指肠切除术治疗非胰腺壶腹周围癌的临床意义：系统评价和个体患者数据分析荟萃分析。
Langenbecks Arch Surg. 2023 Aug 15;408(1):311. doi: 10.1007/s00423-023-03047-4.
7
Pancreatic head cancer: Open or minimally invasive pancreaticoduodenectomy?胰头癌：开放手术还是微创胰十二指肠切除术？
Chin J Cancer Res. 2019 Dec;31(6):862-877. doi: 10.21147/j.issn.1000-9604.2019.06.03.
8
Minimally invasive approaches increase postoperative complications in obese patients undergoing pancreaticoduodenectomy during the initial development period: a propensity score matching study.在初始发展阶段，微创方法会增加接受胰十二指肠切除术的肥胖患者的术后并发症：一项倾向评分匹配研究。
Surg Endosc. 2023 Apr;37(4):2770-2780. doi: 10.1007/s00464-022-09773-y. Epub 2022 Dec 7.
9
Systematic review and meta-analysis of minimally invasive versus open approach for pancreaticoduodenectomy.胰十二指肠切除术微创与开放入路的系统评价和Meta分析
Surg Endosc. 2016 Dec;30(12):5173-5184. doi: 10.1007/s00464-016-4864-3. Epub 2016 Mar 22.
10
A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: Development and validation of predictive model using artificial intelligence.一种用于预测切除后远端胆管癌复发的机器学习预测模型：使用人工智能开发和验证预测模型。
Eur J Surg Oncol. 2024 Jul;50(7):108375. doi: 10.1016/j.ejso.2024.108375. Epub 2024 May 9.
本文引用的文献
1
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.NCCN 指南®洞察：胆道癌，第 2.2023 版。
J Natl Compr Canc Netw. 2023 Jul;21(7):694-704. doi: 10.6004/jnccn.2023.0035.
2
Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma.用于预测预后和指导个体化术后化疗的机器学习模型的开发与验证：一项远端胆管癌的真实世界研究
Front Oncol. 2023 Mar 15;13:1106029. doi: 10.3389/fonc.2023.1106029. eCollection 2023.
3
Long-term Outcomes After Laparoscopic, Robotic, and Open Pancreatoduodenectomy for Distal Cholangiocarcinoma: An International Propensity Score-matched Cohort Study.腹腔镜、机器人和开放胰十二指肠切除术治疗远端胆管癌的长期结果：一项国际倾向评分匹配队列研究。
Ann Surg. 2023 Sep 1;278(3):e570-e579. doi: 10.1097/SLA.0000000000005743. Epub 2022 Nov 1.
4
Vascular resection for distal cholangiocarcinoma.远端胆管癌的血管切除术。
Surg Today. 2023 Aug;53(8):899-906. doi: 10.1007/s00595-022-02634-0. Epub 2022 Dec 23.
5
Robotic versus open pancreaticoduodenectomy for distal cholangiocarcinoma: a multicenter propensity score-matched study.机器人与开腹胰十二指肠切除术治疗远端胆管癌的比较：一项多中心倾向评分匹配研究。
Surg Endosc. 2022 Nov;36(11):8237-8248. doi: 10.1007/s00464-022-09271-1. Epub 2022 May 9.
6
Comparison of postoperative complications and long-term oncological outcomes in minimally invasive versus open pancreatoduodenectomy for distal cholangiocarcinoma: A propensity score-matched analysis.微创与开腹胰十二指肠切除术治疗远端胆管癌的术后并发症和长期肿瘤学结局比较：倾向评分匹配分析。
J Hepatobiliary Pancreat Sci. 2022 Mar;29(3):329-337. doi: 10.1002/jhbp.1067. Epub 2021 Nov 10.
7
Long-term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy combined with portal vein system resection and reconstruction.胰十二指肠切除术联合门静脉系统切除与重建治疗远端胆管癌患者的长期生存。
Langenbecks Arch Surg. 2021 Sep;406(6):1917-1924. doi: 10.1007/s00423-021-02177-x. Epub 2021 Apr 19.
8
Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy.胰十二指肠切除术后淋巴结参数对远端胆管癌的预后影响
World J Surg Oncol. 2020 Oct 8;18(1):262. doi: 10.1186/s12957-020-02040-1.
9
Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival.新型胆外胆管癌糖类抗原（CA）19-9 分期系统及其对总生存期的影响。
Eur J Surg Oncol. 2020 May;46(5):789-795. doi: 10.1016/j.ejso.2020.01.016. Epub 2020 Jan 11.
10
Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma.远端胆管癌手术患者淋巴结比率的预后意义。
J Surg Res. 2019 Apr;236:2-11. doi: 10.1016/j.jss.2018.10.044. Epub 2018 Dec 4.
Zotero 插件